Back

prof. dr. B. (Bas) Oldenburg

prof. dr. B. (Bas) Oldenburg

Full Professor
  • Gastroenterology and Hepatology

Research Programs

Infection & Immunity

Side Activities

Advisory board membership: Takeda, Cablon, Ferring, Abbvie, Janssen, Pfizer, dr. Falk 

Unrestricted grants: Takeda, Abbvie, Janssen

Chair of the post-graduate teaching program of the Dutch Society of Gastroenterology

Auditor of the Dutch GI fellow training program

Member of the Dutch Initiative on Crohn and Colitis (ICC) and the IBD section of the NVMDL

 

Research Output (232)

Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis

van Eijs Mick J.M., ter Linde José J.M., Baars Matthijs J.D., Amini Mojtaba, Laclé Miangela M., Brand Eelco C., Delemarre Eveline M., Drylewicz Julia, Nierkens Stefan, Verheijden Rik J., Oldenburg Bas, Vercoulen Yvonne, Suijkerbuijk Karijn P.M., van Wijk Femke 20 Oct 2023, In: iScience. 26

Cost-effectiveness analysis of increased adalimumab dose intervals in Crohn's disease patients in stable remission:The Randomized Controlled LADI Trial

Jansen Fenna M, van Linschoten Reinier C A, Kievit Wietske, Smits Lisa J T, Pauwels Renske W M, de Jong Dirk J, de Vries Annemarie C, Boekema Paul J, West Rachel L, Bodelier Alexander G L, Gisbertz Ingrid A M, Wolfhagen Frank H J, Römkens Tessa E H, Lutgens Maurice W M D, van Bodegraven Adriaan A, Oldenburg Bas, Pierik Marieke J, Russel Maurice G V M, de Boer Nanne K, Mallant-Hent Rosalie C, Ter Borg Pieter C J, van der Meulen-de Jong Andrea E, Jansen Jeroen M, Jansen Sita V, Tan Adrianus C I T L, Hoentjen Frank, van der Woude C Janneke, 13 Jun 2023, In: Journal of Crohn's & Colitis. 17 , p. 1771-1780 10 p.

Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI):a pragmatic, open-label, non-inferiority, randomised controlled trial

van Linschoten Reinier C.A., Jansen Fenna M., Pauwels Renske W.M., Smits Lisa J.T., Atsma Femke, Kievit Wietske, de Jong Dirk J., de Vries Annemarie C., Boekema Paul J., West Rachel L., Bodelier Alexander G.L., Gisbertz Ingrid A.M., Wolfhagen Frank H.J., Römkens Tessa E.H., Lutgens Maurice W.M.D., van Bodegraven Adriaan A., Oldenburg Bas, Pierik Marieke J., Russel Maurice G.V.M., de Boer Nanne K., Mallant-Hent Rosalie C., ter Borg Pieter C.J., van der Meulen-de Jong Andrea E., Jansen Jeroen M., Jansen Sita V., Tan Adrianus C.I.T.L., van der Woude C. Janneke, Hoentjen Frank, van Noord Desirée, Hoekstra Jildou, Kamphuis Johannes T., Gorter Moniek H.P., van Esch Aura A.J., Apr 2023, In: The Lancet Gastroenterology and Hepatology. 8 , p. 343-355 13 p.

Potential of Mesalazine Therapeutic Drug Monitoring by Measuring Fecal Excretion in Patients With Ulcerative Colitis

van de Meeberg Maartje M, Verheij Elwin R, Fidder Herma H, Bouma Gerd, Huitema Alwin D R, Oldenburg Bas 22 Feb 2023, In: Therapeutic drug monitoring. 45 , p. 668-675 8 p.

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

Kreijne J. E., Goetgebuer R. L., Erler N. S., De Boer N. K., Siebers A. G., Dijkstra G., van Kemenade F. A., Hoentjen F., Oldenburg B., van der Meulen A. E., Ponsioen C. I.J., Pierik M. J., van der Woude C. J., de Vries A. C., 2023, In: Alimentary Pharmacology and Therapeutics. 58 , p. 207-217 11 p.

Endoscopic management of patients with high-risk colorectal colitis-associated neoplasia:a Delphi study

Bak Michiel T J, Albéniz Eduardo, East James E, Coelho-Prabhu Nayantara, Suzuki Noriko, Saito Yutaka, Matsumoto Takayuki, Banerjee Rupa, Kaminski Michal F, Kiesslich Ralf, Coron Emmanuel, de Vries Annemarie C, van der Woude C Janneke, Bisschops Raf, Hart Ailsa L, Itzkowitz Steven H, Pioche Mathieu, Moons Leon M G, Oldenburg Bas 9 Dec 2022, In: Gastrointestinal Endoscopy. 97 , p. 767-779.e6

Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier

Jelinsky Scott A, Derksen Merel, Bauman Eric, Verissimo Carla S, van Dooremalen Wies T M, Roos Jamie Lee, Higuera Barón Celia, Caballero-Franco Celia, Johnson Bryce G, Rooks Michelle G, Pott Johanna, Oldenburg Bas, Vries Robert G J, Boj Sylvia F, Kasaian Marion T, Pourfarzad Farzin, Rosadini Charles V 10 Nov 2022, In: Inflammatory bowel diseases. 29 , p. 195-206 12 p.

Reply:"Anti-TNF Withdrawal in Inflammatory Bowel Disease With Endoscopic Healing and the Risk of Relapse"

Mahmoud R, Savelkoul E H J, Jharap B, Oldenburg B 3 Nov 2022, In: Clinical Gastroenterology and Hepatology. 21 , p. 1967-1968 2 p.

Food processing and risk of Crohn's disease and ulcerative colitis:A European Prospective Cohort Study

Meyer Antoine, Dong Catherine, Casagrande Corinne, Chan Simon, Huybrechts Inge, Nicolas Geneviève, Rauber Fernanda, Levy Renata Bertazzi, Millett Christopher, Oldenburg Bas, Weiderpass Elisabete, Heath Alicia K, Tong Tammy Yn, Tjønneland Anne, Kyrø Cecilie, Kaaks Rudolf, Katzke Verena A, Bergman Manuela M, Palli Domenico, Masala Giovanna, Tumino Rosario, Sacerdote Carlotta, Colorado-Yohar Sandra M, Sánchez Maria-Jose, Grip Olof, Lindgren Stefan, Luben Robert, Gunter Marc J, Mahamat-Saleh Yahya, Boutron-Ruault Marie-Christine, Carbonnel Franck 12 Oct 2022, In: Clinical Gastroenterology and Hepatology. 21 , p. 1607-1616.e6

Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn's disease:a cross-sectional study

van de Meeberg M. M., Seinen M. L., Fidder H. H., Lin M., Oldenburg B., de Boer N. K., Bouma G., de Jonge R., Bulatović Ćalasan M., 30 Jul 2022, In: BMC Gastroenterology. 22

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Contact

Afspraken

Praktisch

hetwkz.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not